{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:02:42Z","timestamp":1710493362470},"reference-count":0,"publisher":"Medinews (Cardiology), Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cardiol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.5837\/bjc.2022.002","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T13:52:36Z","timestamp":1641995556000},"source":"Crossref","is-referenced-by-count":1,"title":["Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategy"],"prefix":"10.5837","member":"3870","published-online":{"date-parts":[[2022]]},"container-title":["British Journal of Cardiology"],"original-title":[],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T13:52:38Z","timestamp":1641995558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjcardio.co.uk\/2022\/01\/foundational-drugs-for-hfref-the-growing-evidence-for-a-rapid-sequencing-strategy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":0,"URL":"https:\/\/doi.org\/10.5837\/bjc.2022.002","relation":{},"ISSN":["0969-6113"],"issn-type":[{"value":"0969-6113","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}